Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 322

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 322
---
                                                    18,071,521      18,061,537      15,747,561  
                                                              27,234,182      29,395,579      31,055,110  

NOTE 16:- REPORTING SEGMENT AND GEOGRAPHIC
INFORMATION

The
Company operates as a single operating segment, with its Chief Executive Officer acting as the Chief Operating Decision Maker (CODM).
The CODM regularly reviews the financial information on a consolidated basis and evaluates the segment’s performance based on its operating
loss, as reported in the consolidated statements of comprehensive loss. This financial metric is used to assess overall business performance
and support resource allocation decisions.

The
following table presents information about the significant expenses regularly provided to the Company’s CODM and included in the
reported measure of segment loss for the years ended December 31, 2022, 2023 and 2024:

                                                          Year ended December 31,                                                            
                                                          2022                                     2023                   2024               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Significant and other segment expenses:                                                                                                    
  Salaries and related benefits, including SBC, net       $                            17,843      $          19,178      $          21,865  
  Clinical trials, subcontractors and materials, net                                    5,536                  7,784                  6,198  
  Professional, legal and marketing expenses                                            5,935                  4,412                  3,149  
  Other segment items 1                                                                 2,822                  4,306                  4,830  
  Financial expenses (income), net                                                      1,606                ( 6,539                ( 4,298  
  Tax on income                                                                            20                     16                      6  
  Segment net loss                                        $                            33,762      $          29,157      $          31,750  

   1      Other segment items included in segment net loss primarily    
          includes rent and related, depreciation and travel expenses.  
 ────────────────────────────────────────────────────────────────────────

F-31

ALPHA TAU MEDICAL
LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 16:- REPORTING SEGMENT AND GEOGRAPHIC